H.C. Wainwright raised the firm’s price target on Microvast (MVST) to $6 from $3 and keeps a Buy rating on the shares. The firm cites strength in the company’s operating performance and higher confidence on the completion of Huzhou 3.2 expansion by Q4 for the target increase. This latter will add two gigawatt-hour of annual production capacity to Microvast’s support growth expectations in 2026 and beyond, the analyst tells investors in a research note.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MVST:
- Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz
- Microvast Holdings Reports Improved Revenue Amid Challenges
- Microvast backs FY25 revenue view $450M-$475M, consensus $469.46M
- Microvast reports Q2 adjusted EPS 5c vs 28c last year
- Microvast Holdings options imply 20.3% move in share price post-earnings
